Not applicableApproved For MarketingNCT01779518
What this trial is testing
Expanded Access Program of Sofosbuvir With Ribavirin and With or Without Pegylated Interferon in Aggressive Post-transplant Hepatitis C
Who this might be right for
Post-transplant Hepatitis C
Gilead Sciences